📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: SyntnX

1.1 - Company Overview

SyntnX Logo

SyntnX

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of needle-free drug delivery solutions, discovering and developing novel, long-acting therapeutic products using proprietary Fc-fusion proteins and other engineered ligands that bind to specific Fc receptors. Technologies include the Transceptor drug delivery platform, harnessing the body's natural pathways.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to SyntnX

Oxyrane Logo

Oxyrane

HQ: United Kingdom Website
  • Description: Provider of novel and biosuperior enzyme replacement therapies for lysosomal storage diseases. Pipeline includes OxyGCase for neuronopathic Gaucher disease and OXY2810 for Pompe disease. Offers the OxyCAT glycoengineered yeast-based platform to produce ERTs with enhanced cellular uptake and pharmacodynamics.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Oxyrane company profile →
XORTX Therapeutics Logo

XORTX Therapeutics

HQ: Canada Website
  • Description: Provider of biopharmaceutical therapies for progressive kidney disease: XRx-008 for ADPKD to reduce cyst growth and improve kidney function; XRx-101 to lower uric acid for acute kidney injury and issues tied to serious viral infections, including COVID-19; and XRx-225, a pre-clinical treatment for Type 2 Diabetic Nephropathy targeting chronic kidney failure and end-stage kidney disease.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full XORTX Therapeutics company profile →
Clementia Pharmaceuticals Logo

Clementia Pharmaceuticals

HQ: Canada Website
  • Description: Provider of clinical-stage, disease-modifying treatments for ultra-rare bone disorders and other debilitating diseases with high unmet medical need, including development of its lead product candidate, palovarotene, an oral small molecule.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Clementia Pharmaceuticals company profile →
Avigen Logo

Avigen

HQ: United States Website
  • Description: Provider of biopharmaceutical R&D focused on treatments for neurological and other disorders. Develops the AV411 portfolio, including a phase II-stage lead drug compound and proprietary analogs, representing novel, non-opioid drugs for the treatment of pain.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Avigen company profile →
Actio Biosciences Logo

Actio Biosciences

HQ: United States Website
  • Description: Provider of rare disease drug discovery and development, with a small molecule TRPV4 program for Charcot-Marie-Tooth disease type 2C and serious bone diseases; a proprietary Rare Disease Target Atlas for target identification and function; a partnership with The Jackson Laboratory to create transgenic models for target evaluation and phenotype analysis; and upcoming programs for genetic epilepsies and genetic skin conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Actio Biosciences company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for SyntnX

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to SyntnX

2.2 - Growth funds investing in similar companies to SyntnX

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for SyntnX

4.2 - Public trading comparable groups for SyntnX

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to SyntnX

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About SyntnX

What does SyntnX do?

SyntnX is a provider of needle-free drug delivery solutions, discovering and developing novel, long-acting therapeutic products using proprietary Fc-fusion proteins and other engineered ligands that bind to specific Fc receptors. Technologies include the Transceptor drug delivery platform, harnessing the body's natural pathways.

Who are SyntnX's competitors?

SyntnX's competitors and similar companies include Oxyrane, XORTX Therapeutics, Clementia Pharmaceuticals, Avigen, and Actio Biosciences.

Where is SyntnX headquartered?

SyntnX is headquartered in United States.

How many employees does SyntnX have?

SyntnX has 1,000 employees 🔒.

When was SyntnX founded?

SyntnX was founded in 2010 🔒.

What sector and industry vertical is SyntnX in?

SyntnX is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for SyntnX

Who are the top strategic acquirers in SyntnX's sector and industry

Top strategic M&A buyers and acquirers in SyntnX's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for SyntnX?

Top strategic M&A buyers groups and sectors for SyntnX include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in SyntnX's sector and industry vertical

Which are the top PE firms investing in SyntnX's sector and industry vertical?

Top PE firms investing in SyntnX's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in SyntnX's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in SyntnX's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in SyntnX's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to SyntnX include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in SyntnX's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for SyntnX?

The key public trading comparables and valuation benchmarks for SyntnX include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for SyntnX for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for SyntnX with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in SyntnX's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for SyntnX with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in SyntnX's' sector and industry vertical?

Access recent funding rounds and capital raises in SyntnX's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for SyntnX